Healthcare-focused private equity firm BelHealth Investment Partners has promoted Nathan Kronforst to managing director and named Jonathan Spero as an associate. Prior to joining BelHealth, Kronforst worked at Celerant Capital where he served as vice president while Spero worked at SunTrust Robinson Humphrey where he was an analyst in the healthcare investment banking division.

Healthcare-focused private equity firm BelHealth Investment Partners has hired Marc Aronstein as a managing director. Previously, Aronstein worked at The Marwood Group where he recently served as a managing director and co-head of private equity investing and M&A.

Qforma, a portfolio company of BelHealth Investment Partners, has named Jeff Brady as executive chairman. Brady is the former CEO of Advanced Health Media. Headquartered in Morris Plains, NJ, Qforma is a provider of advanced analytics for the life sciences sector.

Healthcare-focused private equity firm BelHealth Investment Partners has acquired Precision Toxicology. Headquartered in San Diego, California, the company is a clinical laboratory that specializes in providing quantitative drug testing, primarily for the purpose of helping physicians monitor their patients undergoing treatment for pain or substance abuse.

Linden Care, a provider of specialty pharmacy services to the pain management industry, has added Anthony D. Luna as executive vice president of sales. Linden Care is a portfolio company of BelHealth Investment Partners.

If venture is your bag this week, there are openings aplenty at Canaan Partners, Lanman Ventures and Fenox Venture Capital. On the buyout side, Belhealth Investment Partners and Vista Equity Partners are hiring.

Healthcare-focused private equity firm BelHealth Investment Partners has formed General Genetics Corporation and acquired Genetics Testing Laboratories, Forensic Testing Laboratory and Clinical Testing Laboratories. Based in New Mexico, the labs offer a wide variety of genetic testing services. The labs were established in 2001 at the Arrowhead Research Center on the campus of New Mexico State University.

BelHealth Investment Partners’ portfolio company Qforma, a provider of healthcare data analytics focused on social network tools, stakeholder engagement insights, predictive modeling and launch optimization, has appointed Oern Stuge to the company’s board of directors. Ed Mendham has joined the company as CFO, effective immediately.

Augme Technologies and its wholly-owned subsidiary, Hipcricket, a mobile marketing and advertising technology business, have appointed Michael Brochu to the company’s board of directors as an independent director. Brochu is currently a member of the board of directors for Centro Digital Media, Vines of Mendoza, Zotec Partners and GraphOn Inc. He is also a member of the operating committee of BelHealth Investment Partners, a private equity firm specializing in healthcare, and is on the advisory board of Seattle-based venture capital firm Voyager Capital.

SkilaMederi, a global life-sciences social analytics strategic solutions and launch optimization provider, and Qforma, a provider of advanced analytics and predictive technologies for the life sciences industry, have merged. BelHealth Investment Partners, a healthcare private equity firm and majority owner of SkilaMederi, will support the merger with an additional equity investment.

BelHealth Investment Partners has appointed Paul Barrett to its investment team as an associate. Barrett will be active in executing new transactions and working closely with existing portfolio companies.

Healthcare-focused buyout firm BelHealth Investment Partners has completed its acquisition of specialty pharmacy Town Total Health. BelHealth also announced that healthcare and specialty pharmacy executive Michael A. Nameth has joined Town Total as CEO.